- Home
- LYRA vs LXEH Comparison
LYRA vs LXEH Comparison
Compare LYRA & LXEH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYRA
- LXEH
- Stock Information
- Founded
- LYRA 2005
- LXEH 2001
- Country
- LYRA United States
- LXEH China
- Employees
- LYRA N/A
- LXEH N/A
- Industry
- LYRA Medical/Dental Instruments
- LXEH Other Consumer Services
- Sector
- LYRA Health Care
- LXEH Real Estate
- Exchange
- LYRA Nasdaq
- LXEH Nasdaq
- Market Cap
- LYRA 11.8M
- LXEH 10.5M
- IPO Year
- LYRA 2020
- LXEH 2020
- Fundamental
- Price
- LYRA $0.12
- LXEH $24.53
- Analyst Decision
- LYRA Hold
- LXEH
- Analyst Count
- LYRA 4
- LXEH 0
- Target Price
- LYRA $1.25
- LXEH N/A
- AVG Volume (30 Days)
- LYRA 828.8K
- LXEH 388.0K
- Earning Date
- LYRA 03-13-2025
- LXEH 04-08-2025
- Dividend Yield
- LYRA N/A
- LXEH N/A
- EPS Growth
- LYRA N/A
- LXEH N/A
- EPS
- LYRA N/A
- LXEH N/A
- Revenue
- LYRA $1,534,000.00
- LXEH $5,628,870.00
- Revenue This Year
- LYRA N/A
- LXEH N/A
- Revenue Next Year
- LYRA $519.89
- LXEH N/A
- P/E Ratio
- LYRA N/A
- LXEH N/A
- Revenue Growth
- LYRA N/A
- LXEH N/A
- 52 Week Low
- LYRA $0.12
- LXEH $1.95
- 52 Week High
- LYRA $6.29
- LXEH $39.30
- Technical
- Relative Strength Index (RSI)
- LYRA 23.27
- LXEH 79.60
- Support Level
- LYRA $0.14
- LXEH $9.50
- Resistance Level
- LYRA $0.20
- LXEH $23.42
- Average True Range (ATR)
- LYRA 0.01
- LXEH 4.30
- MACD
- LYRA -0.00
- LXEH 1.28
- Stochastic Oscillator
- LYRA 1.05
- LXEH 51.27
About LYRA Lyra Therapeutics Inc.
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.
About LXEH Lixiang Education Holding Co. Ltd.
Lixiang Education Holding Co Ltd is a private primary and secondary education service provider in Lishui City, Zhejiang Province. Its private education services primarily include primary and middle school education from grade 1 to grade 9. The company also offers high school education services at its High School Divisions.